Impaired subcutaneous insulin delivery in type 2 diabetes patients

被引：0

作者：

Fryk, E. ^{[1
]}

Olausson, J. ^{[2
]}

Strindberg, L. ^{[1
]}

Becattini, B. ^{[1
]}

Mossberg, K. ^{[1
]}

Schmelz, M. ^{[3
]}

Brogren, H. ^{[1
]}

Solinas, G. ^{[1
]}

Jansson, P. -A. ^{[1
]}

机构：

[1] Sahlgrens Univ Hosp, Mol & Clin Med, Gothenburg, Sweden

[2] Sahlgrens Univ Hosp, Dept Clin Microbiol, Gothenburg, Sweden

[3] Med Fac, Dept Expt Pain Res Mannheim, Heidelberg, Germany

来源：

DIABETOLOGIA | 2018年 / 61卷

基金：

瑞典研究理事会;

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

487

引用

页码：S238 / S238

页数：1

共 50 条

[41] A Comparison of Continuous Intravenous Insulin and Subcutaneous Insulin among Patients with Type 2 Diabetes and Congestive Heart Failure Exacerbation
Dungan, Kathleen M.
Osei, Kwame
Gaillard, Trudy R.
Moore, Jared
Binkley, Philip
DIABETES, 2014, 63 : A124 - A124
[42] A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbation
Dungan, Kathleen M.
Osei, Kwame
Gaillard, Trudy
Moore, Jared
Binkley, Philip
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 (01) : 93 - 101
[43] Insulin aspart (IAsp) is as effective in continuous subcutaneous insulin infusion as in multiple daily injections for patients with type 2 diabetes
Raskin, P
Bode, B
Marks, JB
Hirsch, IB
Weinstein, R
McGill, J
Peterson, G
Mudaliar, SR
Reinhardt, R
DIABETES, 2001, 50 : A128 - A128
[44] Continuous subcutaneous insulin infusion is relevant in reducing insulin requirement in patients with type 1 diabetes
Pankowska, E.
Blazik, M.
Groele, L.
DIABETOLOGIA, 2011, 54 : S399 - S399
[45] IMPACT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION ON DIABETES RELATED COMPLICATIONS AND ASSOCIATED COSTS IN TYPE 2 DIABETES PATIENTS IN FINLAND
Roze, S.
Delbaere, A.
de Portu, S.
Bjornstrom, K.
Honkasalo, M.
DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A27 - A28
[46] IMPACT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION ON DIABETES RELATED COMPLICATIONS AND ASSOCIATED COSTS IN TYPE 2 DIABETES PATIENTS IN SWEDEN
Roze, S.
Duteil, E.
Delbaere, A.
De Portu, S.
Brandt, A. S.
Hellman, J.
Frid, A.
DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A19 - A19
[47] Optimization of basal insulin delivery in Type 1 diabetes:: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine
Fahlén, M
Eliasson, B
Odén, A
DIABETIC MEDICINE, 2005, 22 (04) : 382 - 386
[48] Continuous subcutaneous insulin infusion therapy in minority patients with type 1 diabetes
Siegel, L
Almeida, K
Herold, K
Hey-Hadavi, J
Vargas, I
Schachner, H
Tuck, C
Goland, R
DIABETES, 2001, 50 : A445 - A445
[49] Eligibility of patients with Type 1 diabetes in the general diabetes clinic for continuous subcutaneous insulin infusion
Millar, L.
Northover, E.
Morganstein, D. L.
Theodoraki, A.
DIABETIC MEDICINE, 2019, 36 : 77 - 77
[50] Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion
Groop, L
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, : 3 - 13

← 1 2 3 4 5 →